Life Sciences Market - Industry overview, Trends & Report

sale

Ophthalmic Drugs Market

P

2021

Ophthalmic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global ophthalmic drugs market generated $36,488.48 million in 2019, and is projected to reach $58,134.92 million by 2027, growing at a CAGR of 5.6% from 2020 to ...

Report Code : A00220 | Pages : 564 | Category : Life Sciences

Price:

~~$4,065~~ $3,211 (21% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Antipsychotic Drugs Market

P

2021

Antipsychotic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global antipsychotic drugs market size was valued at $12,417.60 million in 2020, and is estimated to reach $26,041.00 million by 2030, growing at a CAGR of 8.0% ...

Report Code : A00338 | Pages : 187 | Category : Life Sciences

Price:

~~$3,712~~ $2,932 (21% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Antiepileptic Drugs Market

P

2024

Antiepileptic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global antiepileptic drugs market was valued at $16.8 billion in 2023, and is projected to reach $27.5 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

Report Code : A00356 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Incretin-Based Drugs Market

P

2023

Incretin-Based Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global incretin-based drugs market was valued at $34.4 billion in 2022, and is projected to reach $73.9 billion by 2032, growing at a CAGR of 7.9% from 2023 to 2032.

Report Code : A00535 | Pages : 250 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Autoimmune Drugs Market

U

2026

Autoimmune Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Autoimmune disease is a condition which results in impaired function and the destruction of tissue, caused by an immune reaction. In autoimmune conditions abnormal antibodies are produced which ...

Report Code : A01154 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Diabetes Drugs Market

P

2024

Diabetes Drugs Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.

Report Code : A01159 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Osteoporosis Drugs Market

P

2020

Osteoporosis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2019–2026

The global osteoporosis drugs market accounted for $7,657 million in 2018, and is expected to reach $10,479 million by 2026, registering a CAGR of 3.9% from 2019 to 2026.

Report Code : A01169 | Pages : 230 | Category : Life Sciences

Price:

~~$3,456~~ $2,696 (22% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Global Human Microbiome Based Drugs and Diagnostics -...

U

2026

Global Human Microbiome Based Drugs and Diagnostics - Opportunities and Forecast, 2014-2022 by Product : Global Opportunity Analysis and Industry Forecast, 2023-2032

Human microbiome drugs and diagnostics basically involves the use of microorganisms of human body for the treatment of diseases. The modern approach involves exploiting the interaction between humans ...

Report Code : A01206 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Anticoagulants Market

P

2018

Anticoagulants Market:

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

Report Code : A01348 | Pages : 215 | Category : Life Sciences

Price:

~~$3,456~~ $2,419 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

HIV Drugs Market

P

2023

HIV Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global HIV drugs market was valued at $32.8 billion in 2022, and is projected to reach $51.1 billion by 2032, growing at a CAGR of 4.5% from 2023 to 2032.

Report Code : A01537 | Pages : 35 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Antifungal Drugs Market

P

2022

Antifungal Drugs Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

The global antifungal drugs market was valued at $16.6 billion in 2020, and is projected to reach $25.0 billion by 2030, growing at a CAGR of 3.9% from 2021 to 2030.

Report Code : A02039 | Pages : 210 | Category : Life Sciences

Price:

~~$3,456~~ $2,419 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Antidepressant Drugs Market

P

2022

Antidepressant Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021–2030

The global antidepressant drugs market size was valued at $15,651.0 million in 2020, and is projected to reach $21,004.8 million by 2030, registering a CAGR of 3.0% from 2021 to 2030.

Report Code : A02261 | Pages : 215 | Category : Life Sciences

Price:

~~$3,712~~ $2,598 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Diuretic Drugs Market

U

2026

Diuretic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Diuretic drugs also termed as ‘water pills’ assists the kidneys eliminate extra water and concentration of sodium and chloride from the body by increasing flow of urine. Diuretic ...

Report Code : A08107 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Thrombosis Drugs Market

U

2026

Thrombosis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Thrombosis drugs are defined as the drugs that inhibit the function of platelets to prevent the formation of clots and inhibit the formation of new clots. These drugs ...

Report Code : A08397 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Atherosclerosis Drugs Market

P

2023

Atherosclerosis Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global atherosclerosis drugs market was valued at $20.6 billion in 2022, and is projected to reach $27.7 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.

Report Code : A13185 | Pages : 250 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Neurodegenerative Drugs Market

P

2023

Neurodegenerative Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global neurodegenerative drugs market was valued at $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031.

Report Code : A13213 | Pages : 300 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Albinism Drugs Market

U

2026

Albinism Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Albinism generally preferred to oculocuntaneous albinism which is group of disorders having no production of pigment melanin. People who suffer from albinism have vision, skin, and hair problems. ...

Report Code : A13333 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Antiglaucoma Drugs Market

U

2026

Antiglaucoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Antiglaucoma drugs are used in the treatment of glaucoma, in which the optic nerve may get damaged resulting in irreversible loss of vision. In glaucoma, excessive amount of ...

Report Code : A13336 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Antithrombotic Drugs Market

U

2026

Antithrombotic Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Antithrombotic drugs help to prevent thrombus or blood clots from forming. These medicines used to reduce the formation of blood clots by reducing the body's ability to form ...

Report Code : A13337 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Dysentery Drugs Market

U

2026

Dysentery Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Dysentery is a type disease related to gastroenteritis that results in bloody diarrhea. Fever, abdominal pain, and feeling of incomplete defections are different types of symptoms occur during ...

Report Code : A13351 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Lifestyle Drugs Market

U

2026

Lifestyle Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Lifestyle drugs are the type of medications used in the treatment of non-threatening and non-painful condition such as baldness, erectile dysfunction, acne, and others. Non-medical problems and minor ...

Report Code : A13368 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Platinum-based Drugs Market

U

2026

Platinum-based Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Prevalence of cancer has witnessed two-fold growth around the globe in recent years, owing to poor lifestyle, increased stress burdens, smocking & alcohol, and use of contraceptives in ...

Report Code : A13436 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Dystonia Drugs Market

P

2023

Dystonia Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global dystonia drugs market was valued at $806.7 million in 2021, and is projected to reach $1,378.67 million by 2031, growing at a CAGR of 5.5% from 2022 to 2031.

Report Code : A13938 | Pages : 210 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Endocrinology Drugs Market

U

2026

Endocrinology Drugs Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Endocrinology is the branch of medicine that deals with endocrine and metabolic disorders. Three different classes of hormones based on their chemical composition include amines, steroids, and peptides & proteins.

Report Code : A13939 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Anticoccidial Drugs Market

P

2022

Anticoccidial Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global anticoccidial drugs market was valued at $171.3 million in 2021, and is projected to reach $257.8 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.

Report Code : A14844 | Pages : 220 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Life Sciences

Filter by Region

Filter by Discounts

Filter by Category

The global ophthalmic drugs market generated $36,488.48 million in 2019, and is projected to reach $58,134.92 million by 2027, growing at a CAGR of 5.6% from 2020 to ...

The global antipsychotic drugs market size was valued at $12,417.60 million in 2020, and is estimated to reach $26,041.00 million by 2030, growing at a CAGR of 8.0% ...

The global antiepileptic drugs market was valued at $16.8 billion in 2023, and is projected to reach $27.5 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

The global incretin-based drugs market was valued at $34.4 billion in 2022, and is projected to reach $73.9 billion by 2032, growing at a CAGR of 7.9% from 2023 to 2032.

Autoimmune disease is a condition which results in impaired function and the destruction of tissue, caused by an immune reaction. In autoimmune conditions abnormal antibodies are produced which ...

The global diabetes drugs market was valued at $79.3 billion in 2023, and is projected to reach $157.9 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033.

The global osteoporosis drugs market accounted for $7,657 million in 2018, and is expected to reach $10,479 million by 2026, registering a CAGR of 3.9% from 2019 to 2026.

Human microbiome drugs and diagnostics basically involves the use of microorganisms of human body for the treatment of diseases. The modern approach involves exploiting the interaction between humans ...

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

The global HIV drugs market was valued at $32.8 billion in 2022, and is projected to reach $51.1 billion by 2032, growing at a CAGR of 4.5% from 2023 to 2032.

The global antifungal drugs market was valued at $16.6 billion in 2020, and is projected to reach $25.0 billion by 2030, growing at a CAGR of 3.9% from 2021 to 2030.

The global antidepressant drugs market size was valued at $15,651.0 million in 2020, and is projected to reach $21,004.8 million by 2030, registering a CAGR of 3.0% from 2021 to 2030.

Diuretic drugs also termed as ‘water pills’ assists the kidneys eliminate extra water and concentration of sodium and chloride from the body by increasing flow of urine. Diuretic ...

Thrombosis drugs are defined as the drugs that inhibit the function of platelets to prevent the formation of clots and inhibit the formation of new clots. These drugs ...

The global atherosclerosis drugs market was valued at $20.6 billion in 2022, and is projected to reach $27.7 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.

The global neurodegenerative drugs market was valued at $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031.

Albinism generally preferred to oculocuntaneous albinism which is group of disorders having no production of pigment melanin. People who suffer from albinism have vision, skin, and hair problems. ...

Antiglaucoma drugs are used in the treatment of glaucoma, in which the optic nerve may get damaged resulting in irreversible loss of vision. In glaucoma, excessive amount of ...

Antithrombotic drugs help to prevent thrombus or blood clots from forming. These medicines used to reduce the formation of blood clots by reducing the body's ability to form ...

Dysentery is a type disease related to gastroenteritis that results in bloody diarrhea. Fever, abdominal pain, and feeling of incomplete defections are different types of symptoms occur during ...

Lifestyle drugs are the type of medications used in the treatment of non-threatening and non-painful condition such as baldness, erectile dysfunction, acne, and others. Non-medical problems and minor ...

Prevalence of cancer has witnessed two-fold growth around the globe in recent years, owing to poor lifestyle, increased stress burdens, smocking & alcohol, and use of contraceptives in ...

The global dystonia drugs market was valued at $806.7 million in 2021, and is projected to reach $1,378.67 million by 2031, growing at a CAGR of 5.5% from 2022 to 2031.

Endocrinology is the branch of medicine that deals with endocrine and metabolic disorders. Three different classes of hormones based on their chemical composition include amines, steroids, and peptides & proteins.

The global anticoccidial drugs market was valued at $171.3 million in 2021, and is projected to reach $257.8 million by 2031, growing at a CAGR of 4.2% from 2022 to 2031.